Over the past 40 years, the safety and efficacy of percutaneous coronary intervention has
dramatically improved by overcoming several challenges. The introduction of drug-eluting …

Coronary disease carries significant morbidity and mortality globally. The pandemic of
obesity and diabetes combined with an aging population have resulted in a significant …

Background: Acute coronary syndrome (ACS) hospital survivors experience a wide array of
late adverse cardiac events, despite considerable advances in the quality of care. We …

Aims: Cardiac lipotoxicity is the common consequence of lipid metabolism disorders in
cardiomyocytes during development of heart failure (HF). Adenosine 5′ monophosphate …

Percutaneous coronary intervention (PCI) has become a standard-of-care procedure in
patients with acute and chronic coronary syndrome. Adjunctive antithrombotic therapy …

Percutaneous coronary intervention (PCI) has become a standard-of-care procedure in the
setting of angina or acute coronary syndrome. Antithrombotic therapy is the cornerstone of …

Patients with cancer have an increased risk of cardiovascular events including myocardial
infarction (MI) and vice versa, and are at high risks of ischemic and bleeding events after MI …

Over the past four decades, percutaneous coronary intervention (PCI) safety and efficacy
have significantly improved, particularly with the advent of the drug-eluting stent (DES). First …

Background Non-ST elevation myocardial infarction (NSTEMI) has higher post-discharge
mortality than ST-elevation myocardial infarction (STEMI). Prognosis worsens in those with …

Background: With the rapid spread of COVID-19, hospitals providing percutaneous coronary
intervention (PCI) were placed in unique and unfamiliar circumstances. This study evaluated …